CAG
LLY icon

Csenge Advisory Group’s Eli Lilly LLY Stock Holding History

Csenge Advisory Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.61M Buy
3,929
+438
+13% +$444K 0.17% 115
2025
Q4 		$3.75M Sell
3,491
-419
-11% -$401K 0.17% 112
2025
Q3 		$2.98M Sell
3,910
-810
-17% -$603K 0.14% 132
2025
Q2 		$3.48M Buy
4,720
+389
+9% +$302K 0.18% 105
2025
Q1 		$3.64M Sell
4,331
-273
-6% -$227K 0.21% 98
2024
Q4 		$3.55M Sell
4,604
-1,370
-23% -$1.13M 0.19% 102
2024
Q3 		$5.57M Buy
5,974
+408
+7% +$367K 0.29% 69
2024
Q2 		$5.04M Buy
5,566
+421
+8% +$337K 0.29% 67
2024
Q1 		$4M Buy
5,145
+933
+22% +$664K 0.22% 83
2023
Q4 		$2.46M Buy
4,212
+73
+2% +$42.6K 0.15% 119
2023
Q3 		$2.22M Buy
4,139
+9
+0.2% +$4.64K 0.15% 121
2023
Q2 		$1.94M Buy
4,130
+669
+19% +$281K 0.13% 126
2023
Q1 		$1.19M Sell
3,461
-14
-0.4% -$4.72K 0.09% 181
2022
Q4 		$1.27M Sell
3,475
-560
-14% -$199K 0.1% 176
2022
Q3 		$1.3M Buy
4,035
+26
+0.6% +$8.24K 0.11% 168
2022
Q2 		$1.3M Buy
4,009
+332
+9% +$99.7K 0.11% 168
2022
Q1 		$1.05M Buy
3,677
+1,002
+37% +$258K 0.08% 204
2021
Q4 		$618K Sell
2,675
-1,655
-38% -$420K 0.06% 294
2021
Q3 		$994K Buy
4,330
+1,655
+62% +$408K 0.08% 220
2021
Q2 		$618K Sell
2,675
-742
-22% -$149K 0.05% 295
2021
Q1 		$630K Sell
3,417
-2,163
-39% -$423K 0.06% 231
2020
Q4 		$942K Sell
5,580
-951
-15% -$142K 0.11% 138
2020
Q3 		$941K Buy
6,531
+333
+5% +$51.5K 0.13% 132
2020
Q2 		$1.02M Buy
6,198
+2,320
+60% +$356K 0.15% 115
2020
Q1 		$538K Buy
3,878
+108
+3% +$14.8K 0.14% 133
2019
Q4 		$495K Buy
3,770
+194
+5% +$22.5K 0.13% 157
2019
Q3 		$400K Buy
+3,576
New +$398K 0.11% 169
2019
Q1 		– Sell
-1,829
Closed -$211K – 206
2018
Q4 		$211K Buy
1,829
+1,300
+246% +$145K 0.08% 176
2018
Q3 		$58K Buy
+529
New +$52.9K 0.02% 281

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Csenge Advisory Group's LLY Position: Q1 2026 in Review

Csenge Advisory Group increased its Eli Lilly (LLY) stake by 13% in Q1 2026, buying an estimated $444K and bringing the position to 3,929 shares worth $3.61M. The position accounts for 0.17% of the portfolio, ranked #115.

Csenge Advisory Group first reported a position in LLY in Q3 2018 and has held it in 29 quarters since. The position peaked at $5.57M in Q3 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Csenge Advisory Group held 3,929 shares of Eli Lilly worth $3.61M as of Q1 2026.
  • Csenge Advisory Group bought 438 Eli Lilly shares in Q1 2026, an estimated $444K.
  • Eli Lilly made up 0.17% of Csenge Advisory Group's portfolio in Q1 2026, its #115 holding.
  • Csenge Advisory Group first reported a position in Eli Lilly in Q3 2018 and has held it in 29 quarters since.
  • Csenge Advisory Group's Eli Lilly position peaked at $5.57M in Q3 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.